The anticoagulant proteins involved in the pathogenesis of coagulation disorders in the course of COVID-19 include thrombomodulin (encoded by the THBD gene) and protein C (encoded by the PROC gene), which are responsible for inhibiting thrombin generation at various stages of its formation. Here, THBD is linked to blood coagulation disease.